[
    {
        "text": "(relaxed music)",
        "start": 1.458,
        "duration": 2.75
    },
    {
        "text": "Thank you so much to \"C&E News\"",
        "start": 6.99,
        "duration": 1.45
    },
    {
        "text": "for including me among this group",
        "start": 8.44,
        "duration": 1.45
    },
    {
        "text": "of really impressive scientists.",
        "start": 9.89,
        "duration": 2.53
    },
    {
        "text": "It's also exciting to be in this session",
        "start": 12.42,
        "duration": 2.21
    },
    {
        "text": "of other chemical biologists.",
        "start": 14.63,
        "duration": 1.92
    },
    {
        "text": "So I'm gonna tell a few short stories",
        "start": 16.55,
        "duration": 1.87
    },
    {
        "text": "about binding drugs for difficult targets.",
        "start": 18.42,
        "duration": 3.02
    },
    {
        "text": "So, first a little bit about my, oops,",
        "start": 21.44,
        "duration": 2.813
    },
    {
        "text": "I clicked too many times.",
        "start": 25.692,
        "duration": 0.988
    },
    {
        "text": "First, a little bit about my background as has been,",
        "start": 26.68,
        "duration": 3.12
    },
    {
        "text": "oh, well, I guess this is gonna go quickly.",
        "start": 29.8,
        "duration": 2.15
    },
    {
        "text": "I grew up across the US.",
        "start": 33.35,
        "duration": 2.14
    },
    {
        "text": "And some early influences in science",
        "start": 35.49,
        "duration": 1.93
    },
    {
        "text": "are from family interest in birding,",
        "start": 37.42,
        "duration": 2.23
    },
    {
        "text": "and also I wanna thank my K-12 science teachers",
        "start": 39.65,
        "duration": 3.56
    },
    {
        "text": "for getting us to do controlled experiments",
        "start": 43.21,
        "duration": 2.71
    },
    {
        "text": "as early as fourth grade.",
        "start": 45.92,
        "duration": 1.39
    },
    {
        "text": "And I studied chemistry in Alanna Schepartz's lab at Yale.",
        "start": 47.31,
        "duration": 3.52
    },
    {
        "text": "I continued as a PhD student, Lu's lab at Harvard,",
        "start": 50.83,
        "duration": 4.11
    },
    {
        "text": "and then I was a postdoc in Kevan Shokat's lab at UCFS.",
        "start": 54.94,
        "duration": 3.96
    },
    {
        "text": "And now, as Lisa mentioned,",
        "start": 58.9,
        "duration": 1.4
    },
    {
        "text": "I'm a scientist at Novartis back in Cambridge.",
        "start": 60.3,
        "duration": 2.62
    },
    {
        "text": "So since it's a bit of a broad group,",
        "start": 62.92,
        "duration": 2.64
    },
    {
        "text": "I thought I'd take a couple of minutes",
        "start": 65.56,
        "duration": 1.61
    },
    {
        "text": "to talk about what is chemical biology,",
        "start": 67.17,
        "duration": 2.0
    },
    {
        "text": "especially because it's an interdisciplinary area",
        "start": 69.17,
        "duration": 2.7
    },
    {
        "text": "of research.",
        "start": 71.87,
        "duration": 0.833
    },
    {
        "text": "And the previous two talks were also great examples",
        "start": 72.703,
        "duration": 2.347
    },
    {
        "text": "of chemical biology research.",
        "start": 75.05,
        "duration": 2.25
    },
    {
        "text": "One definition I would say is that chemical biologists",
        "start": 77.3,
        "duration": 3.53
    },
    {
        "text": "use techniques from chemistry to study biology,",
        "start": 80.83,
        "duration": 2.47
    },
    {
        "text": "often with the goal of inventing new therapeutics.",
        "start": 83.3,
        "duration": 2.5
    },
    {
        "text": "And so to get a little bit more detail than this,",
        "start": 86.78,
        "duration": 2.73
    },
    {
        "text": "these are the questions that the groups that I trained in",
        "start": 89.51,
        "duration": 2.24
    },
    {
        "text": "were asking at the time that I joined.",
        "start": 91.75,
        "duration": 1.91
    },
    {
        "text": "So in the Schepartz lab,",
        "start": 93.66,
        "duration": 1.29
    },
    {
        "text": "I worked on a project that asked the question,",
        "start": 94.95,
        "duration": 2.44
    },
    {
        "text": "how can we introduce therapeutic proteins into the cell,",
        "start": 97.39,
        "duration": 3.22
    },
    {
        "text": "and how can we design therapeutic properties in them?",
        "start": 100.61,
        "duration": 3.13
    },
    {
        "text": "Cell likes to keep things out,",
        "start": 103.74,
        "duration": 1.38
    },
    {
        "text": "and so we successfully managed to get the cell",
        "start": 105.12,
        "duration": 2.86
    },
    {
        "text": "to take up some small peptides.",
        "start": 107.98,
        "duration": 2.3
    },
    {
        "text": "I'd say this is still an ongoing challenge in the field.",
        "start": 110.28,
        "duration": 3.06
    },
    {
        "text": "Now that we've gotten proteins in,",
        "start": 113.34,
        "duration": 1.38
    },
    {
        "text": "we realized the cell chews these things up",
        "start": 114.72,
        "duration": 1.73
    },
    {
        "text": "and they're no longer active.",
        "start": 116.45,
        "duration": 0.95
    },
    {
        "text": "So there are lots of people working on that still.",
        "start": 117.4,
        "duration": 2.98
    },
    {
        "text": "And at the time I joined David Lu's lab,",
        "start": 120.38,
        "duration": 2.06
    },
    {
        "text": "a lot of people were interested in the question,",
        "start": 122.44,
        "duration": 3.131
    },
    {
        "text": "what if we could perform evolution",
        "start": 125.571,
        "duration": 1.739
    },
    {
        "text": "on synthetic small molecules?",
        "start": 127.31,
        "duration": 2.13
    },
    {
        "text": "So in nature, we can see that evolution",
        "start": 129.44,
        "duration": 1.97
    },
    {
        "text": "has led to a huge diversity of form and function",
        "start": 131.41,
        "duration": 3.62
    },
    {
        "text": "in plants and animals.",
        "start": 135.03,
        "duration": 1.29
    },
    {
        "text": "And what if we could take this kind of powerful approach",
        "start": 136.32,
        "duration": 3.24
    },
    {
        "text": "and use it to impart new activities on synthetic compounds.",
        "start": 139.56,
        "duration": 3.703
    },
    {
        "text": "And I'll have a little bit more on that theme in a minute.",
        "start": 144.39,
        "duration": 2.443
    },
    {
        "text": "And then in Kevan's lab and actually continuing today,",
        "start": 148.03,
        "duration": 2.76
    },
    {
        "text": "I'm trying to answer the question,",
        "start": 150.79,
        "duration": 1.27
    },
    {
        "text": "how can we make drugs for difficult undrugged proteins?",
        "start": 152.06,
        "duration": 3.163
    },
    {
        "text": "So I briefly I want to introduce",
        "start": 158.89,
        "duration": 1.62
    },
    {
        "text": "the molecular players in this space.",
        "start": 160.51,
        "duration": 2.02
    },
    {
        "text": "Okay, what's happening?",
        "start": 162.53,
        "duration": 1.54
    },
    {
        "text": "All right.",
        "start": 164.07,
        "duration": 0.833
    },
    {
        "text": "So there are some key molecular players in chemical biology",
        "start": 164.903,
        "duration": 4.487
    },
    {
        "text": "and in the rest of my talk.",
        "start": 169.39,
        "duration": 1.63
    },
    {
        "text": "One is proteins.",
        "start": 171.02,
        "duration": 1.12
    },
    {
        "text": "So these are encoded by the genes",
        "start": 172.14,
        "duration": 2.49
    },
    {
        "text": "that you might've gotten a readout from 23andMe.",
        "start": 174.63,
        "duration": 2.54
    },
    {
        "text": "They could be inside the cell, outside the cell,",
        "start": 177.17,
        "duration": 2.16
    },
    {
        "text": "on the membrane of the cell.",
        "start": 179.33,
        "duration": 1.73
    },
    {
        "text": "And then for my purposes,",
        "start": 181.06,
        "duration": 1.67
    },
    {
        "text": "they're often responsible for driving a disease process.",
        "start": 182.73,
        "duration": 4.09
    },
    {
        "text": "The tool that we're going to use",
        "start": 186.82,
        "duration": 1.4
    },
    {
        "text": "to try to correct that disease process",
        "start": 188.22,
        "duration": 2.64
    },
    {
        "text": "are drug-like small molecules.",
        "start": 190.86,
        "duration": 2.18
    },
    {
        "text": "You can think of these as the active ingredient",
        "start": 193.04,
        "duration": 2.02
    },
    {
        "text": "in a pill that you might take.",
        "start": 195.06,
        "duration": 2.03
    },
    {
        "text": "And what we spend a lot of time doing",
        "start": 197.09,
        "duration": 1.63
    },
    {
        "text": "is trying to find an interaction",
        "start": 198.72,
        "duration": 1.51
    },
    {
        "text": "between the compound and the protein,",
        "start": 200.23,
        "duration": 1.71
    },
    {
        "text": "kind of like a key fitting into a lock.",
        "start": 201.94,
        "duration": 2.71
    },
    {
        "text": "And much like a key fitting into a lock,",
        "start": 204.65,
        "duration": 2.06
    },
    {
        "text": "you can either unlock the door or lock the door.",
        "start": 206.71,
        "duration": 2.99
    },
    {
        "text": "Small molecules, depending on their exact arrangement,",
        "start": 209.7,
        "duration": 2.87
    },
    {
        "text": "can cause different activities",
        "start": 212.57,
        "duration": 1.49
    },
    {
        "text": "in the proteins they interact with.",
        "start": 214.06,
        "duration": 1.75
    },
    {
        "text": "So in graduate school, the focus of my project",
        "start": 217.5,
        "duration": 2.74
    },
    {
        "text": "was trying to make a method to find new interactions",
        "start": 220.24,
        "duration": 3.4
    },
    {
        "text": "between proteins and small molecules as quickly as possible.",
        "start": 223.64,
        "duration": 3.71
    },
    {
        "text": "And so typically when you start a drug discovery campaign,",
        "start": 227.35,
        "duration": 3.47
    },
    {
        "text": "you might test 100,000 to a million compounds,",
        "start": 230.82,
        "duration": 2.93
    },
    {
        "text": "all in separate containers using sophisticated robots",
        "start": 233.75,
        "duration": 3.3
    },
    {
        "text": "that had their start in the automotive industry.",
        "start": 237.05,
        "duration": 3.17
    },
    {
        "text": "With DNA-encoded chemical libraries,",
        "start": 240.22,
        "duration": 2.52
    },
    {
        "text": "this process is miniaturized.",
        "start": 242.74,
        "duration": 1.81
    },
    {
        "text": "There's a barcode on each small molecule made out of DNA,",
        "start": 244.55,
        "duration": 3.55
    },
    {
        "text": "and then you can mix together your whole library,",
        "start": 248.1,
        "duration": 2.25
    },
    {
        "text": "and in fact, orders of magnitude",
        "start": 250.35,
        "duration": 1.5
    },
    {
        "text": "more than what you would screen individually,",
        "start": 251.85,
        "duration": 2.41
    },
    {
        "text": "and test up to in some cases up to 10 to the 10 compounds",
        "start": 254.26,
        "duration": 3.79
    },
    {
        "text": "for its ability to bind a single protein.",
        "start": 258.05,
        "duration": 2.05
    },
    {
        "text": "But of course, we're always interested in multiple proteins,",
        "start": 261.06,
        "duration": 2.85
    },
    {
        "text": "multiple diseases.",
        "start": 263.91,
        "duration": 1.55
    },
    {
        "text": "So we wondered what if we could perform",
        "start": 265.46,
        "duration": 2.86
    },
    {
        "text": "all of these experiments at once.",
        "start": 268.32,
        "duration": 1.39
    },
    {
        "text": "One experiment to test all the interactions",
        "start": 269.71,
        "duration": 2.13
    },
    {
        "text": "you might be interested in.",
        "start": 271.84,
        "duration": 1.68
    },
    {
        "text": "So we wanted to combine all of these different",
        "start": 273.52,
        "duration": 3.11
    },
    {
        "text": "protein-based DNA-encoded library experiments into one tube.",
        "start": 276.63,
        "duration": 3.573
    },
    {
        "text": "And so to do that, we put a DNA barcode",
        "start": 281.58,
        "duration": 2.07
    },
    {
        "text": "on the protein as well.",
        "start": 283.65,
        "duration": 1.47
    },
    {
        "text": "And so now if we get an binding interaction",
        "start": 285.12,
        "duration": 2.15
    },
    {
        "text": "between the protein and the small molecule,",
        "start": 287.27,
        "duration": 1.96
    },
    {
        "text": "sticky ends that we've engineered on the DNA",
        "start": 289.23,
        "duration": 1.97
    },
    {
        "text": "will bind to each other and make a new complex",
        "start": 291.2,
        "duration": 3.97
    },
    {
        "text": "that can be very quickly amplified by PCR,",
        "start": 295.17,
        "duration": 2.92
    },
    {
        "text": "which is really famous to everyone I think.",
        "start": 298.09,
        "duration": 2.46
    },
    {
        "text": "And this rapidly amplified piece of DNA also contains a code",
        "start": 300.55,
        "duration": 4.47
    },
    {
        "text": "for both the small molecule and the protein.",
        "start": 305.02,
        "duration": 2.2
    },
    {
        "text": "So when we used this method",
        "start": 308.31,
        "duration": 1.93
    },
    {
        "text": "to look at about 30,000 interactions all at once,",
        "start": 310.24,
        "duration": 3.62
    },
    {
        "text": "we identified several peaks here",
        "start": 313.86,
        "duration": 2.46
    },
    {
        "text": "which are the rapidly amplified DNA",
        "start": 316.32,
        "duration": 2.63
    },
    {
        "text": "corresponding to both new binding interactions",
        "start": 318.95,
        "duration": 3.57
    },
    {
        "text": "and binding interactions that we had spiked in.",
        "start": 322.52,
        "duration": 2.73
    },
    {
        "text": "So I think this is a really good example",
        "start": 325.25,
        "duration": 1.82
    },
    {
        "text": "of chemical biology",
        "start": 327.07,
        "duration": 1.35
    },
    {
        "text": "because we used a biological molecule, DNA,",
        "start": 328.42,
        "duration": 3.61
    },
    {
        "text": "to try to answer a question that's kind of at the center",
        "start": 332.03,
        "duration": 3.06
    },
    {
        "text": "of both chemistry and biology,",
        "start": 335.09,
        "duration": 1.16
    },
    {
        "text": "how do we identify new binding interactions.",
        "start": 336.25,
        "duration": 2.473
    },
    {
        "text": "It also made me more interested",
        "start": 339.57,
        "duration": 1.6
    },
    {
        "text": "in learning more about the details",
        "start": 341.17,
        "duration": 1.44
    },
    {
        "text": "of these small molecule protein binding interactions.",
        "start": 342.61,
        "duration": 2.49
    },
    {
        "text": "And so that's something that was the focus",
        "start": 345.1,
        "duration": 2.24
    },
    {
        "text": "of my project in the Shokat lab.",
        "start": 347.34,
        "duration": 2.46
    },
    {
        "text": "So when I joined the Shokat lab,",
        "start": 349.8,
        "duration": 1.56
    },
    {
        "text": "they were just a group of people",
        "start": 351.36,
        "duration": 2.35
    },
    {
        "text": "working on a protein called K-Ras,",
        "start": 353.71,
        "duration": 2.24
    },
    {
        "text": "which is a very infamous undrugged target.",
        "start": 355.95,
        "duration": 2.62
    },
    {
        "text": "And thanks to their efforts,",
        "start": 358.57,
        "duration": 1.2
    },
    {
        "text": "it's getting much, much closer to being drugged.",
        "start": 359.77,
        "duration": 2.09
    },
    {
        "text": "There's a lot of molecules under investigation right now.",
        "start": 361.86,
        "duration": 3.58
    },
    {
        "text": "But K-Ras mutations are responsible",
        "start": 365.44,
        "duration": 2.71
    },
    {
        "text": "for up to 200,000 different cases of cancer per year",
        "start": 368.15,
        "duration": 3.4
    },
    {
        "text": "in the US, across a range of tissues.",
        "start": 371.55,
        "duration": 2.99
    },
    {
        "text": "So Kevan and the group had noticed",
        "start": 374.54,
        "duration": 2.19
    },
    {
        "text": "that there are mutations that K-Ras acquires",
        "start": 376.73,
        "duration": 2.67
    },
    {
        "text": "that give it the ability to drive cancer.",
        "start": 379.4,
        "duration": 2.93
    },
    {
        "text": "And one of these mutations is to cystine,",
        "start": 382.33,
        "duration": 3.093
    },
    {
        "text": "abbreviated as cys.",
        "start": 386.62,
        "duration": 1.28
    },
    {
        "text": "Cystine is special for two reasons.",
        "start": 387.9,
        "duration": 2.0
    },
    {
        "text": "One it's not very common,",
        "start": 389.9,
        "duration": 2.12
    },
    {
        "text": "and two, it's more reactive than the other amino acids.",
        "start": 392.02,
        "duration": 3.44
    },
    {
        "text": "So they saw this as an opportunity",
        "start": 395.46,
        "duration": 1.92
    },
    {
        "text": "to form an irreversible reaction",
        "start": 397.38,
        "duration": 2.16
    },
    {
        "text": "with the new cystine on RAS,",
        "start": 399.54,
        "duration": 2.13
    },
    {
        "text": "And that allowed the team",
        "start": 401.67,
        "duration": 1.65
    },
    {
        "text": "to find a new binding pocket on RAS,",
        "start": 403.32,
        "duration": 2.343
    },
    {
        "text": "which allowed them to block the protein",
        "start": 408.437,
        "duration": 1.533
    },
    {
        "text": "in a way that was completely unexpected.",
        "start": 409.97,
        "duration": 2.29
    },
    {
        "text": "And that was really exciting",
        "start": 412.26,
        "duration": 1.31
    },
    {
        "text": "and inspired a lot of academics and industry work.",
        "start": 413.57,
        "duration": 3.98
    },
    {
        "text": "And is now the basis of these compounds",
        "start": 417.55,
        "duration": 2.04
    },
    {
        "text": "that are moving into the clinic.",
        "start": 419.59,
        "duration": 1.78
    },
    {
        "text": "One thing we noticed though is that unfortunately,",
        "start": 421.37,
        "duration": 2.45
    },
    {
        "text": "the cystine mutation is not very common.",
        "start": 423.82,
        "duration": 2.74
    },
    {
        "text": "A much more common mutation",
        "start": 426.56,
        "duration": 1.78
    },
    {
        "text": "in these oncogenic RAS proteins is aspartate.",
        "start": 428.34,
        "duration": 2.673
    },
    {
        "text": "And so the topic of my project",
        "start": 431.88,
        "duration": 2.09
    },
    {
        "text": "was to kind of hijack the chemical matter",
        "start": 433.97,
        "duration": 2.77
    },
    {
        "text": "that had been designed for targeting the cystine in K-Ras",
        "start": 436.74,
        "duration": 4.48
    },
    {
        "text": "and try to change the chemistry",
        "start": 441.22,
        "duration": 3.25
    },
    {
        "text": "so that we could try to react with this aspartate in RAS.",
        "start": 444.47,
        "duration": 3.49
    },
    {
        "text": "So I synthesized this panel of compounds,",
        "start": 447.96,
        "duration": 3.13
    },
    {
        "text": "and my first question was,",
        "start": 451.09,
        "duration": 2.01
    },
    {
        "text": "do any of these react with isolated aspartate in solution.",
        "start": 453.1,
        "duration": 3.86
    },
    {
        "text": "Under kind of idealized conditions,",
        "start": 456.96,
        "duration": 2.19
    },
    {
        "text": "I saw that two aziridines and two diazo groups",
        "start": 459.15,
        "duration": 2.76
    },
    {
        "text": "did efficiently react with aspartate.",
        "start": 461.91,
        "duration": 2.517
    },
    {
        "text": "The next question was,",
        "start": 465.98,
        "duration": 1.28
    },
    {
        "text": "can these compounds label purified K-Ras",
        "start": 467.26,
        "duration": 2.5
    },
    {
        "text": "with the aspartate mutation.",
        "start": 469.76,
        "duration": 1.77
    },
    {
        "text": "Unfortunately, even under kind of forcing",
        "start": 471.53,
        "duration": 2.74
    },
    {
        "text": "non-realistic pH conditions,",
        "start": 474.27,
        "duration": 1.87
    },
    {
        "text": "I did not see much reaction with aspartate on RAS.",
        "start": 476.14,
        "duration": 4.32
    },
    {
        "text": "So that was the end of my work on this project.",
        "start": 480.46,
        "duration": 2.95
    },
    {
        "text": "But I think that this is really still an active area",
        "start": 483.41,
        "duration": 2.97
    },
    {
        "text": "of investigation, probably for a lot of groups,",
        "start": 486.38,
        "duration": 3.213
    },
    {
        "text": "both targeting the aspartate on RAS",
        "start": 490.61,
        "duration": 1.9
    },
    {
        "text": "and other aspartates in general.",
        "start": 492.51,
        "duration": 1.663
    },
    {
        "text": "So now my last short story, as Lisa mentioned,",
        "start": 496.46,
        "duration": 2.64
    },
    {
        "text": "is in the field of targeted protein degradation.",
        "start": 499.1,
        "duration": 2.78
    },
    {
        "text": "This is a really an exploding area of chemical biology.",
        "start": 501.88,
        "duration": 3.67
    },
    {
        "text": "So this area in general asks the question,",
        "start": 505.55,
        "duration": 3.06
    },
    {
        "text": "can we make small molecules",
        "start": 508.61,
        "duration": 1.27
    },
    {
        "text": "that instead of opening or closing the lock,",
        "start": 509.88,
        "duration": 2.56
    },
    {
        "text": "just smash the lock altogether.",
        "start": 512.44,
        "duration": 2.23
    },
    {
        "text": "So it makes use",
        "start": 514.67,
        "duration": 2.0
    },
    {
        "text": "of the cells' normal protein recycling machinery.",
        "start": 516.67,
        "duration": 3.62
    },
    {
        "text": "When the cell wants to get rid of a protein,",
        "start": 520.29,
        "duration": 2.32
    },
    {
        "text": "what happens is that another protein called ubiquitin",
        "start": 522.61,
        "duration": 2.72
    },
    {
        "text": "is attached multiple times.",
        "start": 525.33,
        "duration": 1.98
    },
    {
        "text": "And this is the signal to the cell",
        "start": 527.31,
        "duration": 1.7
    },
    {
        "text": "that that protein should go to the proteasome",
        "start": 529.01,
        "duration": 2.1
    },
    {
        "text": "and get degraded or recycled",
        "start": 531.11,
        "duration": 2.14
    },
    {
        "text": "back into its component amino acids.",
        "start": 533.25,
        "duration": 2.033
    },
    {
        "text": "So in the last few years, chemical biologists realized",
        "start": 536.2,
        "duration": 2.89
    },
    {
        "text": "that they could make molecules here over the central arrow,",
        "start": 539.09,
        "duration": 4.92
    },
    {
        "text": "that recruit new proteins to the machinery",
        "start": 544.01,
        "duration": 3.11
    },
    {
        "text": "that does this ubiquitination function.",
        "start": 547.12,
        "duration": 2.303
    },
    {
        "text": "And that way you can ideally grab any protein",
        "start": 551.29,
        "duration": 3.12
    },
    {
        "text": "that you wanna get rid of in a particular disease,",
        "start": 554.41,
        "duration": 2.12
    },
    {
        "text": "and cause it to be degraded.",
        "start": 556.53,
        "duration": 1.47
    },
    {
        "text": "One thing that's interesting",
        "start": 558.0,
        "duration": 1.24
    },
    {
        "text": "is that there are over 600 different proteins",
        "start": 559.24,
        "duration": 3.17
    },
    {
        "text": "that are members of this complex",
        "start": 562.41,
        "duration": 2.47
    },
    {
        "text": "that are able to add ubiquitin to proteins.",
        "start": 564.88,
        "duration": 3.13
    },
    {
        "text": "But so far only two or three of them",
        "start": 568.01,
        "duration": 2.46
    },
    {
        "text": "have been used for targeted protein degradation.",
        "start": 570.47,
        "duration": 2.82
    },
    {
        "text": "So we wondered whether we make a method",
        "start": 573.29,
        "duration": 2.49
    },
    {
        "text": "that would help people quickly figure out",
        "start": 575.78,
        "duration": 1.76
    },
    {
        "text": "whether or not their protein could be degraded",
        "start": 577.54,
        "duration": 2.22
    },
    {
        "text": "by a new E3 ligase.",
        "start": 579.76,
        "duration": 2.53
    },
    {
        "text": "And so to do this,",
        "start": 582.29,
        "duration": 1.79
    },
    {
        "text": "we also made use of the special reactivity of cystine",
        "start": 584.08,
        "duration": 3.75
    },
    {
        "text": "to form an irreversible complex",
        "start": 587.83,
        "duration": 2.29
    },
    {
        "text": "between a new E3 ligase and an example,",
        "start": 590.12,
        "duration": 2.98
    },
    {
        "text": "a small molecule that binds to a known protein",
        "start": 593.1,
        "duration": 2.49
    },
    {
        "text": "that can be degraded as a test.",
        "start": 595.59,
        "duration": 2.26
    },
    {
        "text": "And then of course that can be extended.",
        "start": 597.85,
        "duration": 2.35
    },
    {
        "text": "So the goal here is to allow people to ask,",
        "start": 600.2,
        "duration": 2.96
    },
    {
        "text": "can this new E3 (indistinct)",
        "start": 603.16,
        "duration": 1.74
    },
    {
        "text": "and targeted protein degradation",
        "start": 604.9,
        "duration": 1.54
    },
    {
        "text": "before going through all the time-consuming work",
        "start": 606.44,
        "duration": 2.55
    },
    {
        "text": "of finding a new small molecule",
        "start": 608.99,
        "duration": 1.83
    },
    {
        "text": "to recruit that E3 ligase.",
        "start": 610.82,
        "duration": 1.677
    },
    {
        "text": "So we have a new pre-print and bio archive.",
        "start": 613.34,
        "duration": 2.34
    },
    {
        "text": "If you're interested, I urge you to check it out.",
        "start": 615.68,
        "duration": 2.21
    },
    {
        "text": "And here's just a little bit of proof of concept data",
        "start": 617.89,
        "duration": 2.82
    },
    {
        "text": "where we showed that we can successfully degrade a protein",
        "start": 620.71,
        "duration": 4.1
    },
    {
        "text": "called BRE4 using a known ligand for BRE4",
        "start": 624.81,
        "duration": 3.17
    },
    {
        "text": "attached to an E3 ligase called VHL.",
        "start": 627.98,
        "duration": 3.06
    },
    {
        "text": "And then if we add inhibitors",
        "start": 631.04,
        "duration": 1.36
    },
    {
        "text": "that either prevent the protease from acting",
        "start": 632.4,
        "duration": 4.24
    },
    {
        "text": "or prevent upstream ubiquitination steps,",
        "start": 636.64,
        "duration": 2.23
    },
    {
        "text": "we see the standard amount of BRE4 as before.",
        "start": 638.87,
        "duration": 3.05
    },
    {
        "text": "I forgot to mention that once we make this complex,",
        "start": 641.92,
        "duration": 1.91
    },
    {
        "text": "we need to get it into cells.",
        "start": 643.83,
        "duration": 1.22
    },
    {
        "text": "And we're doing that using a technique",
        "start": 645.05,
        "duration": 1.55
    },
    {
        "text": "called electroporation where you basically zap the cells,",
        "start": 646.6,
        "duration": 3.06
    },
    {
        "text": "make lots of little holes in the membrane,",
        "start": 649.66,
        "duration": 1.55
    },
    {
        "text": "and then the cell sucks up whatever is around it.",
        "start": 651.21,
        "duration": 3.0
    },
    {
        "text": "So with that,",
        "start": 654.21,
        "duration": 1.2
    },
    {
        "text": "I would like to thank a really large group of people,",
        "start": 655.41,
        "duration": 3.99
    },
    {
        "text": "and this is not exhaustive,",
        "start": 659.4,
        "duration": 1.41
    },
    {
        "text": "who I've had the privilege of working with",
        "start": 660.81,
        "duration": 1.86
    },
    {
        "text": "and being trained by over the years,",
        "start": 662.67,
        "duration": 1.46
    },
    {
        "text": "as well as some really generous funding agencies.",
        "start": 664.13,
        "duration": 2.32
    },
    {
        "text": "And thank you all for joining this virtual session.",
        "start": 666.45,
        "duration": 2.723
    },
    {
        "text": "Awesome, Thank you so much, Lynn,",
        "start": 671.77,
        "duration": 2.32
    },
    {
        "text": "for the great talk and sort of a walk through",
        "start": 674.09,
        "duration": 2.97
    },
    {
        "text": "some of the hot topics in chemical biology too,",
        "start": 677.06,
        "duration": 2.91
    },
    {
        "text": "that you've worked in over the course of your career.",
        "start": 679.97,
        "duration": 4.19
    },
    {
        "text": "I wanted to take a step back",
        "start": 684.16,
        "duration": 1.81
    },
    {
        "text": "and maybe we could just go back",
        "start": 685.97,
        "duration": 3.3
    },
    {
        "text": "to this idea of the new pre-print that has come out",
        "start": 689.27,
        "duration": 4.62
    },
    {
        "text": "in this last slide that you showed us.",
        "start": 693.89,
        "duration": 2.823
    },
    {
        "text": "Maybe you could talk a little bit about the way",
        "start": 698.42,
        "duration": 3.9
    },
    {
        "text": "that people had been making targeted protein degraders",
        "start": 702.32,
        "duration": 3.24
    },
    {
        "text": "in the past?",
        "start": 705.56,
        "duration": 0.99
    },
    {
        "text": "My impression is that's been using",
        "start": 706.55,
        "duration": 1.42
    },
    {
        "text": "a lot of elbow grease and trial and error.",
        "start": 707.97,
        "duration": 2.55
    },
    {
        "text": "It sounds like kind of you're helping",
        "start": 710.52,
        "duration": 1.83
    },
    {
        "text": "to put rational drug design into that process.",
        "start": 712.35,
        "duration": 3.39
    },
    {
        "text": "Maybe you could talk a little bit about that.",
        "start": 715.74,
        "duration": 2.25
    },
    {
        "text": "Yeah, so I think the first couple of E3 ligases",
        "start": 719.0,
        "duration": 2.89
    },
    {
        "text": "are the most popular ones that are used.",
        "start": 721.89,
        "duration": 2.19
    },
    {
        "text": "The chemical matter that recruits them",
        "start": 724.08,
        "duration": 2.48
    },
    {
        "text": "was kind of discovered serendipitously,",
        "start": 726.56,
        "duration": 2.55
    },
    {
        "text": "especially in one case.",
        "start": 729.11,
        "duration": 1.27
    },
    {
        "text": "And since this area has proven so fruitful,",
        "start": 730.38,
        "duration": 2.54
    },
    {
        "text": "now everyone's interested in trying to extend it",
        "start": 732.92,
        "duration": 2.58
    },
    {
        "text": "to more of the 3E ligases.",
        "start": 735.5,
        "duration": 2.65
    },
    {
        "text": "And you're right, that hopefully this will speed things up.",
        "start": 738.15,
        "duration": 2.3
    },
    {
        "text": "because the process of finding a new idea",
        "start": 740.45,
        "duration": 2.267
    },
    {
        "text": "and to recruit each of those E3 ligases",
        "start": 742.717,
        "duration": 3.183
    },
    {
        "text": "is very time-consuming.",
        "start": 745.9,
        "duration": 1.0
    },
    {
        "text": "So if we can have a shortcut to direct efforts",
        "start": 746.9,
        "duration": 2.86
    },
    {
        "text": "to the ones that are going to be productive,",
        "start": 749.76,
        "duration": 1.65
    },
    {
        "text": "hopefully that will help everybody.",
        "start": 751.41,
        "duration": 2.34
    },
    {
        "text": "So is the idea",
        "start": 753.75,
        "duration": 0.86
    },
    {
        "text": "that you then would have to kind of make a compound,",
        "start": 754.61,
        "duration": 3.16
    },
    {
        "text": "test it, see if that's working?",
        "start": 757.77,
        "duration": 1.69
    },
    {
        "text": "Instead you can kind of get ahead of time,",
        "start": 759.46,
        "duration": 3.28
    },
    {
        "text": "sort of take that shortcut?",
        "start": 762.74,
        "duration": 1.743
    },
    {
        "text": "Exactly. Yeah.",
        "start": 767.95,
        "duration": 0.833
    },
    {
        "text": "So some of these hijacking compounds",
        "start": 768.783,
        "duration": 1.937
    },
    {
        "text": "for targeted protein degradation have two pieces.",
        "start": 770.72,
        "duration": 2.59
    },
    {
        "text": "And that makes it maybe twice as time-consuming.",
        "start": 773.31,
        "duration": 2.78
    },
    {
        "text": "You need a piece",
        "start": 776.09,
        "duration": 0.833
    },
    {
        "text": "that recruits your target you wanna degrade.",
        "start": 776.923,
        "duration": 2.047
    },
    {
        "text": "And that recruits the enzyme you want to use to degrade it.",
        "start": 778.97,
        "duration": 3.42
    },
    {
        "text": "And so at least hopefully we can maybe shorten,",
        "start": 782.39,
        "duration": 4.663
    },
    {
        "text": "if you have now an option of 600 different things",
        "start": 788.66,
        "duration": 3.22
    },
    {
        "text": "to degrade that target,",
        "start": 791.88,
        "duration": 1.02
    },
    {
        "text": "how do you decide which one to go after?",
        "start": 792.9,
        "duration": 1.76
    },
    {
        "text": "And at least hopefully we can shortly that step.",
        "start": 794.66,
        "duration": 2.943
    },
    {
        "text": "I think I'll end with one last question",
        "start": 799.113,
        "duration": 2.247
    },
    {
        "text": "because it's interesting",
        "start": 801.36,
        "duration": 1.93
    },
    {
        "text": "to sort of look at how everyone's careers have progressed,",
        "start": 803.29,
        "duration": 3.0
    },
    {
        "text": "and how they've chosen",
        "start": 806.29,
        "duration": 0.833
    },
    {
        "text": "to work on different types of problems.",
        "start": 807.123,
        "duration": 2.567
    },
    {
        "text": "And I'll note that you've kind of gone from (indistinct)",
        "start": 809.69,
        "duration": 5.0
    },
    {
        "text": "to K-Ras and now protein degradation.",
        "start": 815.07,
        "duration": 3.71
    },
    {
        "text": "I'm curious, you're seeing kind of the full suite",
        "start": 818.78,
        "duration": 4.51
    },
    {
        "text": "of what's hot in drug discovery right now.",
        "start": 823.29,
        "duration": 2.34
    },
    {
        "text": "If there's an area that's your favorite,",
        "start": 825.63,
        "duration": 2.18
    },
    {
        "text": "or what has prompted you to sort of I guess",
        "start": 827.81,
        "duration": 3.86
    },
    {
        "text": "do this sampling.",
        "start": 831.67,
        "duration": 1.333
    },
    {
        "text": "Maybe you could talk a little bit about that.",
        "start": 834.24,
        "duration": 2.25
    },
    {
        "text": "Probably I have a short attention span.",
        "start": 838.25,
        "duration": 2.0
    },
    {
        "text": "If I go back to Stuart's talks in the morning,",
        "start": 840.25,
        "duration": 2.12
    },
    {
        "text": "maybe it's best to focus on one thing for 10 years",
        "start": 842.37,
        "duration": 2.82
    },
    {
        "text": "and really make strides in it.",
        "start": 845.19,
        "duration": 2.08
    },
    {
        "text": "So that's something to chew on.",
        "start": 847.27,
        "duration": 2.14
    },
    {
        "text": "But there's definitely lots of new, exciting areas,",
        "start": 849.41,
        "duration": 2.26
    },
    {
        "text": "that if you're a person with a short attention span,",
        "start": 851.67,
        "duration": 1.91
    },
    {
        "text": "you can go into for some time.",
        "start": 853.58,
        "duration": 2.963
    },
    {
        "text": "Do you find yourself learning from,",
        "start": 857.39,
        "duration": 2.67
    },
    {
        "text": "I guess are there pieces from one area that are helping you?",
        "start": 860.06,
        "duration": 3.27
    },
    {
        "text": "Or kind of ways that you solve problems",
        "start": 863.33,
        "duration": 2.28
    },
    {
        "text": "when you worked on a different type of chemical biology,",
        "start": 865.61,
        "duration": 2.7
    },
    {
        "text": "that's helping you as you say go into a different area?",
        "start": 868.31,
        "duration": 4.093
    },
    {
        "text": "Uh-oh, sorry.",
        "start": 879.332,
        "duration": 0.833
    },
    {
        "text": "I don't know if we had a delay issue.",
        "start": 880.165,
        "duration": 1.145
    },
    {
        "text": "But especially the first story and the third story",
        "start": 881.31,
        "duration": 3.58
    },
    {
        "text": "I think have a common theme of method development.",
        "start": 884.89,
        "duration": 2.31
    },
    {
        "text": "So there's definitely a way of thinking about that.",
        "start": 887.2,
        "duration": 1.95
    },
    {
        "text": "Of kind of prototyping something, testing it,",
        "start": 889.15,
        "duration": 3.66
    },
    {
        "text": "figuring out what area needs to be tweaked,",
        "start": 892.81,
        "duration": 1.99
    },
    {
        "text": "and kind of turning through that a little bit.",
        "start": 894.8,
        "duration": 3.74
    },
    {
        "text": "Wonderful.",
        "start": 898.54,
        "duration": 0.833
    },
    {
        "text": "Well, thank you so much, Lynn.",
        "start": 899.373,
        "duration": 1.507
    },
    {
        "text": "We were glad to have your talk and have you on our list.",
        "start": 900.88,
        "duration": 3.662
    },
    {
        "text": "(relaxed music)",
        "start": 904.542,
        "duration": 2.75
    }
]